NeuroDerm to Present at Upcoming Investor Conferences

REHOVOT, Israel, March 02, 2016 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq: NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that CEO Oded S. Lieberman, PhD will present at the following investor conferences:

• Cowen and Company 36th Annual Health Care Conference taking place in Boston, Massachusetts from March 7 – 9, 2016.  Dr. Lieberman’s presentation will take place on Wednesday, March 9, at 11:20am ET.
• 28th Annual ROTH Conference taking place in Dana Point, California from March 13 – 16, 2016. Dr. Lieberman’s presentation will take place on Monday, March 14 at 9:30am PT, 12:30pm ET.

To access the live webcast of the presentations, please visit ir.neuroderm.com/.  A replay will be available following the presentation.

About NeuroDermNeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhanced clinical efficacy through continuous, controlled administration. NeuroDerm is headquartered in the Rabin Science Park, Rehovot, Israel.

NeuroDerm Contact:Oded S. Lieberman, PhD MBA, CEO[email protected]Tel.: +972-8-946 2729Cell: +1-617-517 6077

U.S. Investor Contact:David CareyLazar Partners Ltd.[email protected]+212-867-1762

You May Also Be Interested In

• HIVE Reports Q1 2027 Revenue of $79.1 Million; Contracted GPU Cloud ARR(1) Reaches Approximately $110 million
• SoonLab Launches SoonLab 2.0, Bringing More Intelligent AI Agents to Game Creation
• SentinelGuard Trailers Deployed at Shabang Festival and St. Fratty's Day